Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HeartWare Presents New VAD Data; Thrombus Rates Prompt Concerns

This article was originally published in The Gray Sheet

Executive Summary

HeartWare presented longer-term data from its bridge-to-transplant ADVANCE trial for its left ventricular assist device earlier this month. The data largely mirrored results presented last year, but newly increased thrombus rates prompted questions.

You may also be interested in...



Thoratec Downplays Threats From Competing HeartWare Pump

Thoratec’s virtual monopoly in the LVAD market is about to end with the anticipated launch of HeartWare’s system this month or next, but executives are not displaying major concern.

Research In Brief

Neurostim for migraine?

Research In Brief

Neurostim for migraine?

Related Content

UsernamePublicRestriction

Register

MT030063

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel